Is Zimmer Biomet Stock Underperforming the Nasdaq? As Zimmer Biomet has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain cautious about the stock’s prospects. Barchart · Sep 16
Are Wall Street Analysts Bullish on Zimmer Biomet Stock? Zimmer Biomet has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects. Barchart · Aug 14
Earnings Preview: What To Expect From Zimmer Biomet’s Report Here’s what analysts are expecting out of Zimmer Biomet’s upcoming Q2 earnings report. Barchart · Jul 22
Is Zimmer Biomet Stock Underperforming the S&P 500? Zimmer Biomet has lagged the broader S&P 500 Index over the past year, and analysts remain on the sidelines as they weigh the company's steady fundamentals against its modest growth outlook. Barchart · Jun 15
What Are Wall Street Analysts' Target Price for Zimmer Biomet Stock? As Zimmer Biomet has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects. Barchart · May 15
Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know Zimmer Biomet is poised to report its first-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings. Barchart · Apr 10
How Is Zimmer Biomet Holdings’ Stock Performance Compared to Other Medical Devices Stocks? Zimmer Biomet Holdings stock has lagged other medical device stocks over the past year, while analysts are neutral about its prospects. Barchart · Mar 16
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH With after-tax profits surging by close to 50% year-over-year, AstraZeneca emerges as a potential winner among healthcare names reporting earnings this month. MarketBeat · Feb 12
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish? Zimmer Biomet has trailed the broader market over the past year, and it continues to face skeptical sentiment from analysts regarding its near- to medium-term growth outlook. Barchart · Feb 11
Zimmer Biomet’s Q3 2025 Earnings: What to Expect Zimmer Biomet is poised to report its fourth-quarter results in the near future, and Wall Street anticipates a measured, single-digit increase in earnings. Barchart · Jan 13
Zimmer Biomet Stock: Is ZBH Underperforming the Health Care Sector? Despite Zimmer Biomet's underperformance relative to the broader healthcare sector over the past year, the stock is still viewed by analysts with moderate optimism. Barchart · Dec 10, 2025
Zimmer Biomet Stock: Analyst Estimates & Ratings Zimmer Biomet has significantly underperformed the broader market and other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects. Barchart · Nov 12, 2025
Is Zimmer Biomet Stock Underperforming the Dow? Although Zimmer Biomet has lagged behind the Dow over the past year, analysts remain moderately optimistic about the stock’s prospects. Barchart · Sep 17, 2025
Do Wall Street Analysts Like Zimmer Biomet Stock? While Zimmer Biomet has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects. Barchart · Aug 18, 2025
Benzinga · Aug 7, 2025 Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.
Barchart · Jul 17, 2025 What You Need To Know Ahead of Zimmer Biomet's Earnings Release Zimmer Biomet is expected to announce its second-quarter results in the upcoming month, and analysts expect a low-single-digit drop in earnings.
Benzinga · Jul 14, 2025 Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Monday agreed to acquire Monogram Technologies Inc. (NASDAQ:MGRM) for an upfront payment of $4.04 per share, corresponding to an equity value of approximately $177 million and an enterprise value of approximately $168 million.
Barchart · Jun 17, 2025 Is Zimmer Biomet Stock Underperforming the Nasdaq? Zimmer Biomet has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Barchart · May 15, 2025 Zimmer Biomet Stock Outlook: Is Wall Street Bullish or Bearish? Zimmer Biomet has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Barchart · Apr 22, 2025 What to Expect From Zimmer Biomet's Next Quarterly Earnings Report Zimmer Biomet is gearing up to report its first-quarter results next month, with market expectations pointing to a single-digit decrease in earnings.
Barchart · Apr 16, 2025 Zimmer Biomet Hits 34th 52-Week Low: Value Play or Value Trap? Zimmer Biomet hit its 34th 52-week low on Tuesday. Its shares have decreased by over 20% in the past year. Trading at just 11.8x the 2025 EPS estimate, the maker of orthopedic medical devices looks cheap.
Barchart · Mar 24, 2025 Is Zimmer Biomet Stock Outperforming the S&P 500? Zimmer Biomet has recently surged past the S&P 500 Index, with analysts maintaining a cautiously upbeat outlook on its growth potential.
Barchart · Mar 16, 2025 1 Stock to Buy ASAP to Cash in on the Pickleball Craze As pickleball injuries rise, this medical device stock is perfectly positioned to cash in on the sport’s booming popularity.
StockNews.com · Feb 27, 2025 3 Healthtech Stocks Making Healthcare More Accessible The healthcare market is fueling digital transformation by improving efficiency and fostering personalized care, making it an attractive investment opportunity. Hence, investors might consider investing in healthcare stocks, such as Teladoc Health (TDOC), Zimmer Biomet Holdings (ZBH), and Cardinal Health (CAH). Read more….
Barchart · Feb 14, 2025 Are Wall Street Analysts Predicting Zimmer Biomet Stock Will Climb or Sink? Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.